Market Overview:
The global lancing devices for blood testing market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about blood sugar levels, and technological advancements in lancing devices. Based on type, the global lancing devices for blood testing market is segmented into personal lancets and professional lancets. Personal lancets are used by individuals for self-testing, while professional lancets are used by healthcare professionals in hospitals and clinics. The personal segment is expected to account for the majority of the market share during the forecast period owing to its growing popularity among consumers for home care use. Based on application, the global lancing devices for blood testing market is segmented into home care and hospital & clinics. Home care is further sub-segmented into self-testing and point-of-care testing (POC). Hospital & clinics are sub-segmented into central laboratory testing (CLT) and bedside monitoring/point of care (BPM/POC). The home care segment accounted for a larger share of the global market in 2017 due to its growing demand among consumers worldwide for convenient diagnostics at their homes. However, with increasing demand from emerging markets such as Asia Pacific and Latin America, hospital & clinic applications are projected to witness higher growth rates during the forecast period.
Product Definition:
A lancing device is a medical device that is used to prick the skin in order to obtain a blood sample. The use of lancing devices for blood testing is important because it allows healthcare professionals to obtain accurate blood test results.
Personal Lancets:
Personal lancets are used for drawing blood from patients. They are reusable and can be autoclaved for sterilization. The most common use of personal lancets is in the testing of hemoglobin, hematocrit, and blood volume. These devices help to obtain small volumes of sample at regular intervals which helps in minimizing patient’s time and also reduces cost associated with it.
Professional Lancets:
Professional lancets are used in lancing devices for blood testing. These devices are available in different forms such as disposable and reusable. Reusable ones have a longer life span as compared to the disposable type due to which they are more expensive. The major factor that influences the market is the frequency of use of these products, since they need replacement after each usage, thus influencing its demand over a period of time.
The major factors that propel professional lancets.
Application Insights:
The global market is segmented by application into home care, hospital and clinics, and others. The home care segment dominated the overall market in terms of revenue in 2017 owing to increasing awareness about the benefits of lancing devices for blood testing among consumers. Furthermore, an increase in the prevalence of diabetes has led to a significant rise in demand for self-monitoring blood glucose testing devices such as lancets. This trend is expected to continue over the forecast period due to rising disposable income levels coupled with population growth across developing countries such as India and China.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for advanced lancing devices are some of the factors responsible for its large share. Moreover, increasing demand to curb rising incidence of chronic diseases is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to growing target population base with high blood pressure and diabetes coupled with improving economic status in countries such as India and China. Furthermore, an increase in government initiatives aimed at curbing disease transmission will also boost regional product demand over the next eight years. ‰â€˜Blood donor day' has been celebrated on 28th April every year since 2010 by WHO (World Health Organization) along with International Blood Group Federation (IBDF).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases such as heart disease, stroke, cancer, and diabetes accounted for 63% of all deaths in 2012. This number is expected to rise to 73% by 2030. This will create a large demand for lancing devices for blood testing as they are used for diagnosing these conditions.
- Technological advancements: Lancing devices have undergone significant technological advancements in recent years, thanks to advances in medical technology. These devices are now more accurate and user-friendly than ever before, which has led to their increased adoption rates worldwide.
- Growing awareness about blood sugar levels: There is growing awareness among people about the importance of maintaining healthy blood sugar levels both for preventing and managing chronic diseases such as diabetes mellitus type 2 (DM2). As a result, there is increasing demand for lancing devices that can help users measure their blood sugar levels accurately and conveniently at home or on-the-go..
Scope Of The Report
Report Attributes
Report Details
Report Title
Lancing Devices for Blood Testing Market Research Report
By Type
Personal Lancets, Professional Lancets
By Application
Home Care, Hospital & Clinics
By Companies
Roche, Owen Mumford, Ascensia, B. Braun, Terumo, ARKRAY, Trividia Health, SANNUO, BIONIME, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Lancing Devices for Blood Testing Market Report Segments:
The global Lancing Devices for Blood Testing market is segmented on the basis of:
Types
Personal Lancets, Professional Lancets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Home Care, Hospital & Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Owen Mumford
- Ascensia
- B. Braun
- Terumo
- ARKRAY
- Trividia Health
- SANNUO
- BIONIME
- Roche
Highlights of The Lancing Devices for Blood Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Personal Lancets
- Professional Lancets
- By Application:
- Home Care
- Hospital & Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lancing Devices for Blood Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lancing devices are medical devices that use a sharp object to pierce the skin and draw blood. They are used for blood testing, including tests for cholesterol, glucose, and other substances.
Some of the key players operating in the lancing devices for blood testing market are Roche, Owen Mumford, Ascensia, B. Braun, Terumo, ARKRAY, Trividia Health, SANNUO, BIONIME, Roche.
The lancing devices for blood testing market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lancing Devices for Blood Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lancing Devices for Blood Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lancing Devices for Blood Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lancing Devices for Blood Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lancing Devices for Blood Testing Market Size & Forecast, 2020-2028
4.5.1 Lancing Devices for Blood Testing Market Size and Y-o-Y Growth
4.5.2 Lancing Devices for Blood Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Personal Lancets
5.2.2 Professional Lancets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Home Care
6.2.2 Hospital & Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lancing Devices for Blood Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lancing Devices for Blood Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Personal Lancets
9.6.2 Professional Lancets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Home Care
9.10.2 Hospital & Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Personal Lancets
10.6.2 Professional Lancets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Home Care
10.10.2 Hospital & Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Personal Lancets
11.6.2 Professional Lancets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Home Care
11.10.2 Hospital & Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Personal Lancets
12.6.2 Professional Lancets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Home Care
12.10.2 Hospital & Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Personal Lancets
13.6.2 Professional Lancets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Home Care
13.10.2 Hospital & Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lancing Devices for Blood Testing Market: Competitive Dashboard
14.2 Global Lancing Devices for Blood Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Owen Mumford
14.3.3 Ascensia
14.3.4 B. Braun
14.3.5 Terumo
14.3.6 ARKRAY
14.3.7 Trividia Health
14.3.8 SANNUO
14.3.9 BIONIME
14.3.10 Roche
